FDA MedWatch Recall Notice - Hellolife Issues Voluntary Worldwide Recall of Neuroveen, Respitrol, Thyroveev and Compulsin due to Possible Microbial Contamination

If your email program has trouble displaying this email, view it as a web page

MedWatch - The FDA Safety Information and Adverse Event Reporting Program A new MedWatch Safety Alert recall: Hellolife, Inc. Issues Voluntary Worldwide Recall of Neuroveen, Respitrol, Thyroveev and Compulsin due to Possible Microbial Contamination was just added to the FDA Recalls webpage.   You can read the complete recall alert at: https://www.fda.gov/Safety/Recalls/ucm618926.htm

U.S. Food and Drug Administration 10903 New Hampshire Avenue, Silver Spring, MD 20993 1-888-INFO-FDA (1-888-463-6332) Privacy Policy | www.fda.gov Manage Preferences or Unsubscribe from this List | Unsubscribe from all Email Lists